Osler
PrivateLast Round
Series C
Nov 7, 2022
Est. Valuation
$88.54M
Total Funding Raised
$172M
Company Overview
Osler Diagnostics is a healthcare technology company that develops a blood sampling and testing device capable of accurately analyzing a variety of biomarkers from a single drop of blood, facilitating decentralized diagnostics for health monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine, Sensors
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Osler Comps
Public and private peers based on sector, stage, and business model.
Osler Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 7, 2022 | ||||
| Series B | Nov 20, 2020 | ||||
| Series A | Dec 20, 2018 | ||||
| Seed | Jul 1, 2016 |
Osler Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Braavos Investment Advisers | Series C |
| Oxford Science Enterprises | Seed |
| Oxford Technology Investment Fund | Seed |
| M&G Investments | Series C |
| Lansdowne Partners | Series C |
Osler Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Osler's valuation, stock price, and market status.